
Singapore · Biotechnology
RVAC Medicines is an mRNA platform company with a pipeline of novel products covering a wide range of disease areas.
PrivateFor profit
Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.
Across all 5.9M companies: larger than 75% of those with a size listed; older than 0% of those with a founding year.
BiotechnologyMedicalProduct Research
What the source datasets report. We have not watched these rounds ourselves.
$140M
raised in total, currency not stated across 1 round
Last raised Apr 2022, 4 years ago
Everything the source datasets list about RVAC Medicines, field by field. Contact details are held but never shown.
The company6 fields
Where3 fields
Size and reach1 field
Funding, as listed7 fields
About this record2 fields
55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.